There are no Focus articles on MCET.
There are no Transcripts on MCET.
We currently have no Breaking News on this stock.
MCET vs. ETF Alternatives
MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease, fatigue of MS and cancer. The majority owned Xenogenics subsidiary is... More
Other News & PR